Diabetic agents, from metformin to SGLT2 inhibitors and GLP1 receptor agonists: JACC focus seminar

Citation
Wilcox T, De Block C, Schwartzbard AZ, Newman JD. J Am Coll Cardiol 2020;75:1956–74.